Table 2.
Distribution of outcomes reported by the study population and the respective difference in prevalence and kappa statistics.
| Outcomes | Influenza n (%) |
COVID-19 n (%) | Difference in Prevalence | Kappa Coefficient (p-Value) |
|---|---|---|---|---|
| Allergies * Medication-related Other than medication-related |
54 (24.8) 34 (15.6) 33 (15.1) |
72 (33.0) 39 (17.9) 45 (20.6) |
0.06 0.3 0.07 |
0.59 (<0.001) 0.50 (<0.001) 0.79 (<0.001) |
| Chronic medication use | 71 (32.6) | 89 (40.8) | 0.03 | 0.63 (<0.001) |
| Chronic diseases | 69 (31.7) | 78 (35.8) | 0.18 | 0.40 (<0.001) |
| One disease | 54 (24.8) | 61 (28.0) | ||
| Multiple diseases | 15 (6.9) | 17 (7.8) |
* Numbers do not sum up to the total because of missing information on the specific allergies.